Although we have demonstrated that intravenous administration of recombinant human MG53 (rhMG53) protein could protect against acute heart injury in rodent and porcine models of ischemia-reperfusion–induced MI (5, 10), whether rhMG53 has beneficial effects on chronic HF remains to be determined. Here, TRIM72 is linked to hydrops fetalis.